Ten days after receiving a second dose of a messenger RNA, or mRNA, vaccine for COVID-19, patients without COVID-19 symptoms
Read more
Developers of Russian Sputnik V Vaccine Doubt EU Regulator’s Neutrality, Want Apology
MOSCOW (Reuters) – The developers of Russia’s Sputnik V vaccine against COVID-19 on Tuesday questioned the European Medicines Agency’s (EMA)
Read more
Immune interference: Why even ‘updated’ vaccines could struggle to keep up with emerging coronavirus strains
Despite the success and optimism of the new COVID-19 vaccination campaigns being rolled out worldwide, the emergence of new viral
Read more
New evidence COVID-19 antibodies, vaccines less effective against variants
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus
Read more
EU Regulator Plans to Fast Track Variant-Modified COVID Vaccines
(Reuters) – Europe’s medicines regulator said on Thursday it has issued new guidance for drug makers that modify their COVID-19
Read more
Hong Kong advisory panel approves China's Sinovac COVID-19 vaccine for emergency use
FILE PHOTO: Vials of the Sinovac’s vaccine for the coronavirus disease (COVID-19) are seen inside a vaccine carrier at a
Read more
UK to consider making excess vaccines available to other nations after its adults inoculated, official says
FILE PHOTO: British Vaccine Deployment Minister Nadhim Zahawi speaks at the House of Commons in London, Britain February 4, 2021.
Read more
EU to speed approval of variant-modified coronavirus vaccines: paper
Slideshow ( 2 images )FRANKFURT (Reuters) – The European Union will fast track approvals of coronavirus vaccines adapted to combat
Read more
Around 1 in 10 Americans Have Received at Least 1 COVID Vaccine Dose, but Supply Issues Remain
Around 1 in 10 Americans have now received at least one dose of a COVID-19 vaccine, according to data from
Read more
Anxiety grows as long-term care awaits COVID-19 vaccines
Frustration is building over the pace of COVID-19 vaccinations at long-term care sites, where some homes still await first shots
Read more